Thromboembolism: all 818 studies

Page 3 of 9. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.

• Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).CompletedNCT00986154Phase 3Results posted
• The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedNCT00981409Phase 3Results posted
• Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management SystemCompletedNCT00978445Not applicableResults posted
• Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement SurgeryTerminatedNCT00967447Results posted
• Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsCompletedNCT00966277Phase 4Results posted
• Fragmin for the Treatment of Acute VTE in Pediatric Cancer PatientsCompletedNCT00952380Phase 2Results posted
• Applying Pharmacogenetic Algorithms to Individualize Dosing of WarfarinCompletedNCT00927862Phase 2/3Results posted
• Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.CompletedNCT00878826Phase 2/3Results posted
• A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer PatientsTerminatedNCT00876915Phase 3Results posted
• Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement SurgeryCompletedNCT00847301Results posted
• Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement SurgeryCompletedNCT00846807Results posted
• Prothrombin Times Outside the Therapeutic Range in Otherwise Stable PatientsCompletedNCT00814177Phase 2Results posted
• Self-management of Low Molecular Weight Heparin TherapyCompletedNCT00794560Phase 4Results posted
• Aspirin Prophylaxis for Venous Thromboembolism in GlioblastomaTerminatedNCT00790452Phase 2Results posted
• Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed ThrombolysisCompletedNCT00790335Phase 3Results posted
• A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical ProphylaxisTerminatedNCT00789399Not applicableResults posted
• Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)CompletedNCT00786474Phase 3Results posted
• Once Weekly Subcutaneous Ports for the Administration of AnticoagulantsCompletedNCT00774748Not applicableResults posted
• Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)CompletedNCT00680186Phase 3Results posted
• Long-term Active Surveillance Study for Oral Contraceptives (LASS)CompletedNCT00676065Results posted
• Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip ArthroplastyCompletedNCT00657150Phase 3Results posted
• Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)CompletedNCT00634907Not applicableResults posted
• Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill PatientsCompletedNCT00571649Phase 3Results posted
• Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTECompletedNCT00558259Phase 3Results posted
• Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.CompletedNCT00556426Not applicableResults posted
• The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma PatientsCompletedNCT00531843Phase 2/3Results posted
• Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous ThromboembolismCompletedNCT00523614Results posted
• A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial FibrillationCompletedNCT00504556Phase 2Results posted
• Celect Vena Cava Filter Clinical TrialCompletedNCT00470626Not applicableResults posted
• Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical PatientsTerminatedNCT00445328Phase 4Results posted
• Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension StudyCompletedNCT00439725Phase 3Results posted
• D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous ThromboembolismTerminatedNCT00428441Not applicableResults posted
• Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous ThromboembolismTerminatedNCT00423683Phase 3Results posted
• Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerCompletedNCT00381888Phase 2Results posted
• Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)CompletedNCT00375609Phase 2Results posted
• Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.CompletedNCT00362232Phase 3Results posted
• Secondary Prevention of Venous Thrombo Embolism (VTE).CompletedNCT00329238Phase 3Results posted
• Hip Fracture Study of GSK576428 (Fondaparinux Sodium)CompletedNCT00320424Phase 3Results posted
• A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) CancerCompletedNCT00320255Phase 2Results posted
• Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous ThromboembolismCompletedNCT00291330Phase 3Results posted
• A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.CompletedNCT00246025Phase 2Results posted
• Odiparcil For The Prevention Of Venous ThromboembolismCompletedNCT00244725Phase 2Results posted
• Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement SurgeryCompletedNCT00168818Phase 3Results posted
• RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee SurgeryCompletedNCT00168805Phase 3Results posted
• Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee ReplacementCompletedNCT00152971Phase 3Results posted
• Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular DiseaseCompletedNCT00071032Phase 3Results posted
• Effect of Tranexamic Acid on Bleeding After Bariatric SurgeryCompletedNCT07754396
• Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive TransfusionCompletedNCT07290634
• Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) StudyActive, not recruitingNCT07008508
• Diffrence in Thromboprofilaksis in Elderly Ostoepenic Hip Fractures According to Mobility Status by Genetic AnalysisActive, not recruitingNCT06959017Not applicable
• Recurrence of Thromboembolic Venous Disease of Atypical Location (RUSE)Active, not recruitingNCT06815874
• Venous Thromboembolism During COVID-19 Pandemic: Evaluation of the Association With the Vaccine and COVID-19 InfectionCompletedNCT06806800
• Prediction of Systemic Thromboembolism and Bleeding in Atrial Fibrillation Patients With Factor Xa Inhibitor (Apixaban, Rivaroxaban) by Echocardiographic Parameters: Prospective Observational Study (AF-ECHO Study)Active, not recruitingNCT06779695
• Thromboembolic Complications in Mild Covid-19 CasesCompletedNCT06695377
• Efficacy of Aspirin in Preventing Venous ThromboembolismCompletedNCT06635317Phase 4
• Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint ReplacementActive, not recruitingNCT06627933
• A Study to Learn How Safe BAY3018250 is, How it Moves Into, Through and Out of the Body, and How it Affects the Body in Healthy Chinese ParticipantsCompletedNCT06619483Phase 1
• The Affect Of An Anti-Embolism Stocking ProtocolCompletedNCT06616376Not applicable
• The Safety and Effectiveness of Warfarin Vs Apixaban in Patients with NVAF/ VTE and ESKD on DialysisCompletedNCT06606275
• A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 YearsCompletedNCT06562985Phase 1
• Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer PatientsCompletedNCT06556953
• Determination of Venous Thromboembolism Risk and Nursing Practices in Patients Hospitalized in Medical ServicesCompletedNCT06445283
• Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized PatientsActive, not recruitingNCT06443905
• Evaluation of the Effect of Drug-Related Problems in Pulmonary EmbolismCompletedNCT06392672Not applicable
• Risk Factors of Venous Thromboembolism After Colorectal Cancer SurgeryCompletedNCT06302179
• Venous Thrombo-Embolism Imaging Database (VTE-ID)CompletedNCT06258694
• Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm RepairCompletedNCT06238115Phase 2/3
• Pregnancy and Postpartum Period Venous Thromboembolism and SimulationActive, not recruitingNCT06218095Not applicable
• Effect of a Global Simplified Strategy on Thromboembolic Events in Emergency Department Patients with Suspected Pulmonary EmbolismCompletedNCT06190392Not applicable
• Safety of Direct Oral Anticoagulant During PregnancyCompletedNCT06179823
• Elaboration of a Prioritization Score for Pharmaceutical Interviews in Patients Treated With Oral AnticoagulantsCompletedNCT06100380
• Thromboembolic Complications in COVID-19 Patients in Intensive Care UnitCompletedNCT06037707
• Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 PatientsCompletedNCT05926518
• Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum StudyCompletedNCT05897697
• The Effect of Sock Developed with Wearable Technology for TUR Surgery Patients on Hypothermia and Venous ThromboembolismWithdrawnNCT05887518Not applicable
• Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled TrialCompletedNCT05878899Phase 3
• COVID-19 Vaccination Detoxification in LDL-CActive, not recruitingNCT05839236Phase 1
• Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With EnoxaparinTerminatedNCT05819125
• A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical IllnessTerminatedNCT05819112
• SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedNCT05752461Phase 2
• DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme InducersActive, not recruitingNCT05750680
• Risk Factors and Prediction Model of Cancer-associated Venous ThromboembolismStatus unknownNCT05729464
• The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKDActive, not recruitingNCT05656963
• TINzaparin Prophylaxis in Patients With Metastatic Colorectal CancerCompletedNCT05625932Phase 3
• Thromboembolism in Anorexia NervosaCompletedNCT05575466
• Atrial Fibrillation and Cancer: a Nationwide French Cohort StudyActive, not recruitingNCT05563883
• Venous Thromboembolism (VTE) KnowledgeCompletedNCT05548010
• Thrombosis in Patients With Multiple Myeloma in an University Medical CenterCompletedNCT05541978
• A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood ClotWithdrawnNCT05536791
• Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized PatientsStatus unknownNCT05515549
• Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic EventsCompletedNCT05515120Phase 2/3
• Predicting the Risk of Venous Thromboembolism in Critically Ill PatientsStatus unknownNCT05498142
• Efficacy of ICU-VTE Scale in ICU PatientsCompletedNCT05487066
• An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World SettingCompletedNCT05471830
• VTE and the Related Factors Associated With Higher Rates of PE After a DVT in Southwestern ChinaCompletedNCT05464901
• An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)CompletedNCT05461807
• A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver FunctionCompletedNCT05419635Phase 1
• Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective StudyActive, not recruitingNCT05396157
• Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous ThromboembolismStatus unknownNCT05382481Not applicable
• Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic EventsCompletedNCT05313620Phase 4

← Thromboembolism overview